Document Detail

Pulmonary hypertension in chronic liver disease.
MedLine Citation:
PMID:  8665788     Owner:  NLM     Status:  MEDLINE    
Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed.
M S Mandell; B M Groves
Related Documents :
20216168 - Nursing considerations in the care of patients with pulmonary hypertension.
2252188 - Life-threatening complications during anaesthesia in a patient with a ventriculo-atrial...
18200808 - Review of bosentan in the management of pulmonary arterial hypertension.
12391278 - Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary...
19692438 - Aortic posterior wall perforation with automatic aortic cutter during routine off-pump ...
23812198 - Spontaneously remitted pulmonary arterial hypertension associated with the herbal medic...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in chest medicine     Volume:  17     ISSN:  0272-5231     ISO Abbreviation:  Clin. Chest Med.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-08-08     Completed Date:  1996-08-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7907612     Medline TA:  Clin Chest Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  17-33     Citation Subset:  IM    
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chronic Disease
Endothelium, Vascular
Hypertension, Portal / complications*,  diagnosis,  surgery
Hypertension, Pulmonary / diagnosis,  drug therapy,  etiology*,  mortality,  physiopathology
Liver Diseases / complications,  physiopathology,  surgery
Liver Transplantation
Lung / blood supply
Survival Rate
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Vasodilator Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mediators, cytokines, and growth factors in liver-lung interactions.
Next Document:  Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease.